Home
Polar Capital Holdings reported a 5.17% stake in Enliven Therapeutics ELVN · 2,536,881 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.17%
- Last report
- 4.89% · filed 25/02/14
- Shares held
- 2,536,881 sh
- Class
- Common Stock, $0.001 par value per share
- Holder
- Polar Capital Holdings
- Event date
- 25/06/30
- Filed
- 25/08/14
5.17% stake · +0.3pp from the last report
- Stake
- 5.17%
- Last report
- 4.89%
- Since last report
- +0.3pp
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Polar Capital Holdings's other 5% stake reports
- Polar Capital Holdings
5% stakeArcutis Biotherapeutics
5% stakeArcutis Biotherapeutics
ARQT
5.28% stake
6,606,945 sh
5.28% stake
Filed 08/14
- Polar Capital Holdings
5% stakeVerastem
5% stakeVerastem
VSTM
4.8% stake
3,700,000 sh
4.8% stake
Filed 07/08
- Polar Capital Holdings
5% stakeEnliven Therapeutics
5% stakeEnliven Therapeutics
ELVN
8.47% stake
59,800,406 sh
8.47% stake
Filed 05/15
- Polar Capital Holdings
5% stakeVerastem
5% stakeVerastem
VSTM
5.09% stake
3,398,898.71 sh
5.09% stake
Filed 01/05
- Polar Capital Holdings
5% stakeHagerty
5% stakeHagerty
HGTY
5.85% stake
5,306,865 sh
5.85% stake
Filed 25/09/04
